Direct enhancement of viral neutralising antibody potency by the complement system: a largely forgotten phenomenon.
Journal article
Mellors J. and Carroll M., (2024), Cellular and molecular life sciences : CMLS, 81
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents.
Journal article
Ratcliffe H. et al, (2023), iScience, 26
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients.
Journal article
Murray SM. et al, (2023), Journal of hepatology
A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2.
Journal article
Wilkinson T. et al, (2023), ERJ open research, 9, 249 - 2023
CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study.
Journal article
Neale I. et al, (2023), mBio
Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members
Journal article
Jay C. et al, (2023), Frontiers in Immunology, 14
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history.
Journal article
Hornsby H. et al, (2023), Nature communications, 14
Corrigendum: Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2.
Journal article
Thursz M. et al, (2023), The Journal of general virology, 104
Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy.
Journal article
Williams DM. et al, (2023), iScience, 26
Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2.
Journal article
Thursz M. et al, (2023), The Journal of general virology, 104
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination.
Journal article
Johnson SA. et al, (2023), Clinical and experimental immunology, 212, 249 - 261
Mammalian expression systems and vaccination
Chapter
Carroll MW. et al, (2023), Genetically Engineered Viruses: Development and Applications, 107 - 157
Linked Mutations in the Ebola Virus Polymerase Are Associated with Organ Specific Phenotypes.
Journal article
Dong X. et al, (2023), Microbiol Spectr
Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine
Journal article
Brewitz L. et al, (2023), Journal of Medicinal Chemistry, 66, 2663 - 2680
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens.
Journal article
Moore SC. et al, (2023), Med (N Y)
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform.
Journal article
Bojkova D. et al, (2023), iScience, 26
Influence of Landscape Patterns on Exposure to Lassa Fever Virus, Guinea
Journal article
Longet S. et al, (2023), Emerging Infectious Diseases, 29, 304 - 313
Omicron BA.1/BA.2 infections in triple-vaccinated individuals enhance a diverse repertoire of mucosal and blood immune responses
Preprint
Hornsby H. et al, (2023)
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus
Journal article
Fidler S. et al, (2023), Clinical Infectious Diseases, 76, 201 - 209
Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents.
Journal article
Jay C. et al, (2023), Frontiers in immunology, 14
Pre-clinical models to define correlates of protection for SARS-CoV-2.
Journal article
Brady C. et al, (2023), Frontiers in immunology, 14
Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial.
Journal article
Donovan-Banfield I. et al, (2022), Nat Commun, 13
An introduction to the Marburg virus vaccine consortium, MARVAC.
Journal article
Cross RW. et al, (2022), PLoS pathogens, 18
Avatar Mice Underscore the Role of the T Cell-Dendritic Cell Crosstalk in Ebola Virus Disease and Reveal Mechanisms of Protection in Survivors.
Journal article
Rottstegge M. et al, (2022), Journal of virology
Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model.
Journal article
Wing PAC. et al, (2022), PLoS pathogens, 18
A prototype lateral flow assay for detection of orthopoxviruses.
Journal article
Ulaeto DO. et al, (2022), The Lancet. Infectious diseases, 22, 1279 - 1280
Evolutionary implications of human transmission of monkeypox: the importance of sequencing multiple lesions.
Journal article
Ulaeto DO. et al, (2022), The Lancet. Microbe, 3, e639 - e640
Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
Journal article
McNaughton AL. et al, (2022), JCI Insight, 7
Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization.
Journal article
Harvala H. et al, (2022), Transfusion, 62, 1347 - 1354
SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients
Journal article
Shankar S. et al, (2022), Journal of the American Society of Nephrology, 33, 883 - 887
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction.
Journal article
Guimond SE. et al, (2022), ACS central science, 8, 527 - 545
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
Journal article
Ogbe A. et al, (2022), JCI Insight, 7
Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing
Journal article
Salam AP. et al, (2022), PLOS Neglected Tropical Diseases, 16, e0010289 - e0010289
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Journal article
Tomic A. et al, (2022), Nature Communications, 13
Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytes.
Journal article
Gray-Rodriguez S. et al, (2022), The Journal of pathology
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Journal article
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15
Sequential Delivery of Live Attenuated Influenza Vaccine and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Ferret Model Can Reduce SARS-CoV-2 Shedding and Does Not Result in Enhanced Lung Pathology.
Journal article
Ryan KA. et al, (2022), The Journal of infectious diseases, 225, 404 - 412
Advances and gaps in SARS-CoV-2 infection models.
Journal article
Muñoz-Fontela C. et al, (2022), PLoS pathogens, 18
Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers
Journal article
Dong X. et al, (2022), GigaScience, 11
Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.
Journal article
Mellors J. et al, (2022), Frontiers in immunology, 13
Development of anti-Crimean-Congo hemorrhagic fever virus Gc and NP-specific ELISA for detection of antibodies in domestic animal sera.
Journal article
Belij-Rammerstorfer S. et al, (2022), Frontiers in veterinary science, 9
mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals.
Journal article
Longet S. et al, (2022), Frontiers in immunology, 13
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2
Journal article
Huang K-YA. et al, (2022), Theranostics, 12, 1 - 17
The characterization of multiple novel paramyxoviruses highlights the diverse nature of the subfamily Orthoparamyxovirinae.
Journal article
Vanmechelen B. et al, (2022), Virus evolution, 8
Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses.
Journal article
Gartlan C. et al, (2022), Frontiers in immunology, 13
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
Journal article
Tan TK. et al, (2021), Nature Communications, 12
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models
Journal article
Lambe T. et al, (2021), Communications Biology, 4
Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013–16 West Africa epidemic
Journal article
Tipton TRW. et al, (2021), Nature Communications, 12
Quantification of type i interferon inhibition by viral proteins: Ebola virus as a case study
Journal article
Locke M. et al, (2021), Viruses, 13